Effect of zinc supplementation in patients with type C liver cirrhosis
Kazuhiro Katayama(Osaka International Cancer Institute), Toshifumi Ito(The University of Osaka), Kazuyoshi Ohkawa(Osaka International Cancer Institute), Masafumi Naito(Osaka Hospital), Kazuho Imanaka(Osaka International Cancer Institute), Takashi Matsunaga(Shiga University of Medical Science), Mitsuru Sakakibara(The University of Osaka)
Cited by 13
Related Papers
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
|European Journal of Cancer|2011|573
Validation of A New Prognostic Staging System for Hepatocellular Carcinoma: the Jis Score Compared With the Clip Score
|Hepatology|2004|359
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)
|Hepatology Research|2023|281
Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis
|Journal of Gastroenterology|2009|205